Synlett 2018; 29(11): 1451-1554
DOI: 10.1055/s-0037-1610132
letter
© Georg Thieme Verlag Stuttgart · New York

Pharmaceutical-Oriented Methoxylation of Aryl C(sp2)–H Bonds using Copper Catalysts

Guofu Zhang
a   College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: dingcr@zjut.edu.cn
,
Jianfei Zhu
a   College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: dingcr@zjut.edu.cn
,
Chaolai Tong
b   Jianxing Honor College, Zhejiang University of Technology, Hangzhou 310014, P. R. of China
,
Chengrong Ding*
a   College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: dingcr@zjut.edu.cn
› Author Affiliations
We acknowledge financial support from the National Natural Science Foundation of China (no. 20702051), the Natural Science Foundation of Zhejiang Province (LY13B020017), and the Key Innovation Team of Science and Technology in Zhejiang Province (no. 2010R50018).
Further Information

Publication History

Received: 22 January 2018

Accepted after revision: 08 April 2018

Publication Date:
02 May 2018 (online)


Abstract

A pharmaceutical-oriented, copper(II)-catalyzed methoxylation of aryl C(sp2)–H bonds has been developed. This simple and environmentally benign reaction system occurs efficiently using oxygen as oxidant with broad substrate scope and high functional group tolerance.

Supporting Information